StemCell Therapy

Cannabis with THC levels over 10 per cent became the strongest predictor of success in treating migraine- and headache-related pain.

For the first time, researchers have focused on dried cannabis flower as treatment for headaches and migraines.

Published in the Journal of Integrative Medicine, the study examined, in real time, the associations between different product characteristics and changes in symptom intensity following cannabisuse.

Interestingly, results showcased that flower was, indeed, effective for migraines, but the specifics of the cannabis plant (gender, age and combustion methods) may decrease effectiveness.

One key finding determined that cannabis with tetrahydrocannabinol (THC) levels over 10 per cent became the strongest predictor of success in treating migraine- and headache-related pain with cannabis.

Additionally, the C. indica strain offered greater success with individuals in the study over its C. sativa counterpart. Overall, for those seeking migraine relief and for healthcare professionals looking to treat those who have headaches, the study could be an important conversation starter for better outcomes against pain.

Results of the study offer insight into how cannabis looks to not only alleviate, but could eliminate, migraine pain for some users. With more than 94 per cent of users experiencing symptom relief within two hours, the study has brought to light deeper conversations around cannabis role in pain and quality-of-life for those experiencing headache-related disorders.

The research joins another study that looked into the prolonged use of cannabis for individuals who suffer migraines. Published in May in Brain Sciences, the study found that frequent cannabis use decreased migraine frequency.

Another study found that frequent cannabis use decreased migraine frequency. / Photo: iStock / Getty Images PlusiStock / Getty Images Plus

These findings indicate that MC [medical cannabis] results in long-term reduction of migraine frequency in more than 60 per cent of treated patients and is associated with less disability and lower anti-migraine medication intake.

Cannabis and CBD have attracted interest in migraine treatments in the last few years with organizations looking to alternative medicine to offer a needed solution for those who dont want to use opioids.

The Migraine Research Foundation gave Dr. Nathaniel Schuster from the University of California San Diego funding for his research on cannabis in 2018. Additionally, the American Headache Society and the American Migraine Foundation have both expressed the need for more research around cannabis and CBD for migraine relief.

The FreshToast.com, a U.S. lifestyle site that contributes lifestyle content and, with their partnership with 600,000 physicians via Skipta, medical marijuana information to The GrowthOp.

Want to keep up to date on whats happening in the world of cannabis?Subscribeto the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network

Go here to see the original:
What a new study reveals about cannabis and migraines - The GrowthOp

This entry was posted on August 14, 2020 at 2:48 pm and is filed under Integrative Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |